Metraipolis › archive › dc_2f3f699bda78
The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes — Europe PMC PMID:41011719
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41011719
- DOI
- 10.3390/molecules30183828
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T20:25:01.381Z
- SHA-256 of the archived text
c43eeb61b5f09106b0b97ab20a3be1b7f67697f81c67f4674e08b120bce46b6f- Stable URL of this page
https://metraipolis.com/documento/dc_2f3f699bda78
How to cite
The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes — Europe PMC PMID:41011719 — Europe PMC (en), https://europepmc.org/article/MED/41011719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f3f699bda78 (Metraipolis archive dc_2f3f699bda78, sha256 c43eeb61b5f09106b0b97ab20a3be1b7f67697f81c67f4674e08b120bce46b6f)
BibTeX
@misc{dc2f3f699bda78,
title = {The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes — Europe PMC PMID:41011719},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41011719},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f3f699bda78; sha256 c43eeb61b5f09106b0b97ab20a3be1b7f67697f81c67f4674e08b120bce46b6f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011719. Agents can read the archived copy with the MCP tool read_document.